Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Not Confirmed
Not Confirmed
22-24 April, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry
16 Apr 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/
02 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/02/3054142/0/en/Biogen-s-Investigational-Tau-Targeting-Therapy-BIIB080-Receives-FDA-Fast-Track-Designation-for-the-Treatment-of-Alzheimer-s-Disease.html
01 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250331812163/en/Organon-Acquires-TOFIDENCE-tocilizumab-bavi-a-Commercialized-Biosimilar-to-ACTEMRA-tocilizumab-Injection-for-Intravenous-Infusion-in-the-U.S.
25 Mar 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/biogen-plots-2028-headquarters-shift-new-innovation-hub-cambridge
18 Mar 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125104
13 Mar 2025
// HEALTH CANADA
Inspections and registrations
ABOUT THIS PAGE
Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen
Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen
Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen